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ABSTRACT
Objective: To present the results obtained from surgical 
treatment of patients with vertebral metastases, comparing 
them with the modified Tokuhashi score in order to valida-
te the applicability of this score for prognostic predictions 
and for choosing surgical treatments. Methods: This was 
a retrospective study on 157 patients treated surgically for 
spinal metastasis in Erastus Gaertner Hospital in Curitiba. 
The Tokuhashi score was applied retrospectively to all the 
patients. The patients’ actual survival time was compared 
with the expected survival time using the Tokuhashi score. 
Results: There were 82 females and 75 males. The most 
frequent location of the primary tumor was the breast. 
The thoracic region was involved in 66.2%, lumbar region 
in 65.6%, cervical region in 15.9% and sacral region in 
12.7%. All the patients underwent surgical treatment. The 
most frequent indication for treatment was intractable pain 
Rev Bras Ortop. 2011;46(4):424-30
INTRODUCTION
With the progressive increase in overall survival 
among patients with bone metastasis, oncologists are 
increasingly faced with cases of secondary bone le-
sions. Knowledge of the principles for treating such 
lesions therefore becomes necessary, so that patients 
can be provided with improved quality of life(1). 
The aim in treating metastatic bone lesions is 
to provide patients with improved quality of life 
through controlling pain and achieving partial or full 
functional recovery(2,3).
(89.2%). There was partial or complete improvement in a 
majority of the cases (52.2%). Out of 157 cases studied, 
86.6% died. The maximum survival time was 13.6 years, 
the minimum was 3 days and the mean was 13.2 months. 
The following frequencies of Tokuhashi scores were found 
among the operated cases: up to 8 points, 111 cases; 9-11 
points, 43 cases; and 12-15 points, three cases. The mean 
survival time in months for all 157 patients according to 
the Tokuhashi score was: 0-8 points, 15.4 months; 9-11 
points, 11.4 months; and 12-15 points, 12 months. Con-
clusion: Unlike the nonsurgical approach recommended by 
Tokuhashi for patients with lower scores, this group in our 
study was sent for surgery, with better results than those of 
non-operated patients reported by Tokuhashi.
Keywords - Neoplasm Metastasis; Spine; Survivorship 
(Public Health) 
Vertebral metastatic disease is difficult to treat, and 
the prognosis for the patient’s life is the main factor in 
making therapeutic decisions(3). The treatment options 
include conservative measures without surgery, such 
as hormone therapy, chemotherapy/radiotherapy and 
palliative treatment for pain; and surgical measures, 
which include complete excision of the lesion, repla-
cement of the vertebra with an endoprosthesis and 
decompression and stabilization by means of posterior 
and/or anterior routes. 
There is a consensus that surgical intervention is 
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thrombosis, pulmonary thromboembolism, pneumo-
nia, atelectasis and other clinical complications that 
put the patient’s life into immediate risk. Physicians 
have the duty to intervene at the right moment and 
with the necessary degree of aggressiveness, because 
the evolution of the condition often will not allow 
future interventions and such patients end up pro-
gressing to death under very poor conditions in terms 
of quality of life.
The aim of this study was to present the results ob-
tained from treating patients with vertebral metastases 
surgically, comparing their real length of survival with 
the length of survival expected according to the modi-
fied Tokuhashi scale, for each score group, in order to 
validate the applicability of this scale for prognostic 
predictions and for choosing the surgical therapy. 
MATERIAL AND METHODS
Between the years 1993 and 2008, 157 patients 
with metastatic disease in the spine were assessed 
and treated surgically at our service. In conformity 
with the routine protocol, they underwent compu-
ted tomography scans on the cervical, thoracic and 
lumbar-sacral spine, in order to analyze all segments 
of the spine, as well as examinations to investigate 
other metastatic sites and to investigate primary sites 
if the primary site was unknown. The following data 
were tabulated: age, primary tumor, sex, location of 
the metastasis, preoperative neurological state accor-
ding to the Frankel scale (Box 1), improvement in 
pain after the operation using a visual analogue pain 
scale (Figure 1) and the final evolution of the case 
(survival or death).
Box 1 – Classification of the patients based on the initial 
neurological condition, according to Frankel. 
FRANKEL CLASSIFICATION
A - Absence of motor or sensory function below the level of the 
lesion
B - Absence of motor function, but with some degree of sensitivity 
preserved below the level of the lesion
C - Come degree of motor function but without practical usefulness
D - Useful motor function below the level of the lesion
E - Normal sensory and motor function, although there may be 
some abnormality of reflexes
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indicated in the following cases of vertebral metas-
tatic lesion: spinal cord compression with myelopa-
thy; vertebral instability with intractable mechanical 
pain; dislocated fractures of the spine; radiculopathy 
with progressive or uncontrollable symptoms; tumor
growth even after radiotherapy; and direct extension 
of the primary tumor in the spine, for example in 
cases of Pancoast tumor(4,5). 
Strategies for surgical treatment of vertebral metas-
tases have been determined according to the prognosis 
for each patient’s life. One way to determine these 
patients’ prognosis is to use the Tokuhashi score, which 
has recently been revised. This takes into account six 
parameters that measure the severity of the clinical 
picture: 1) general condition; 2) number of bone me-
tastases outside of the spine; 3) number of metastases 
in vertebral bodies; 4) metastases to important internal 
organs; 5) primary site of the cancer; and 6) paralysis 
according to the Frankel scale (Box 1). Each parameter 
is graded with score of between 0 and 2 points. Zero 
signifies a poor prognosis(6,7). From the scores obtai-
ned, the patients are allocated to different survival 
prognosis groups: from 0 to 8 points, six months of 
survival; from 9 to 11 points, six to twelve months of 
survival; and from 12 to 15 points, more than twelve 
months of survival.  
With regard to treatment, choosing the ideal the-
rapy continues to be a challenge, but this can be faci-
litated through standardizing the approach based on 
scales like the Tokuhashi score(8,9) .
Keeping patients in bed for several days when 
they are affected by metastatic lesions in the spine 
cannot be accepted. In such situations, there would 
be a high likelihood of evolution involving deep vein 
Figure 1 – Visual analogue pain scale.
The indications for surgical treatment were the 
following: spinal cord compression with myelopa-
thy; spinal instability manifested as fractures, pro-
gressive deformation, progressive neurological deficit 
and intractable pain; radiculopathy with progressive 
or uncontrollable symptoms; and tumor growth even 
after radiotherapy or chemotherapy. 
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The treatment methods used were: stabilization 
of the spine with fixation between segments (using 
pedicle screws or sublaminar wires and Hartshill 
rectangle); spinal cord decompression together with 
stabilization; and curative surgery with resection of 
the tumor lesion. 
A retrospective cohort study was conducted, in 
which the Tokuhashi scores (Box 2, 3 and 4; and
Figure 2) were applied retrospectively to all the pa-
tients, in order to evaluate the applicability of the 
scale to the cases studied. The patients’ real length 
of survival was compared with the length of sur-
vival that was expected according to the modified 
Tokuhashi score. 
Box 2 - Tokuhashi classification.
Characteristics Points




2 - Metastases outside of vertebra
Three or more 0
One or two 1
None 2
3 - Metastases in vertebra
Three or more 0
One or two 1
None 2





Lings, osteosarcoma, stomach, bladder, esophagus 
and pancreas
0
Liver, gallbladder and unknown 1
Others 2
Kidney and uterus 3
Rectum, thyroid and breasts 4
Prostate and carcinoid 5
6 - Neurological state
Frankel A and B 0
Frankel B and C 1
Frankel D and E 2






Box 4 – Survival according to the modified Tokuhashi index.
Score Survival in months
0-8 points 6 months
9-11 points 6-12 months
12-15 points More than 12 months
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Figure 2 – Strategy for treating metastases according to modified 
Tokuhashi. 
RESULTS
Out of the total of 157 patients, 82 (52.2%) were 
female and 75 (47.8%) were male. The mean age was 
53.9 years, with a minimum of 15 and maximum of 84.
Regarding the primary site of the neoplasm, the 
most frequent sites were the breasts (25.5%) and pros-
tate (21%). The other cases are specified in Box 5.
Regarding the location of the lesion in the spine, 
the thoracic region was affected in 66.2%, lumbar 
region in 65.6%, cervical region in 15.9% and sa-
cral region in 12.7% (Box 6). In 50.3% of the cases, 
the tumor only involved one segment of the spine; 
in 39.5%, two segments; 9.5%, three segments; and 
0.7%, four segments (Box 7).
All the patients underwent surgical treatment, and 
the most common form of treatment was spinal cord 
decompression and fixation with pedicle screws. 
The most frequent indication for surgical treatment 
was intractable pain, which accounted for 89.2% of the 
cases. In 39.5%, the indication was paraplegia and in 
35.7%, paresthesia. The other symptoms are shown in 
Table 8. Box 9 shows the number of symptoms pre-
sented per patient before the operation. It can be seen 
that 68.1% presented two or more symptoms together.
The preoperative Frankel classification is shown 
in Box 10.
Strategy for Treating Metastases in Spine
Conservative Treatment
Palliative Surgery





In relation to the improvement of the symptoms 
after the operation, it was observed that there was par-
tial or full alleviation of the pain in the majority of the 
cases (52.2%) (Box 11). The criterion for assessing 
the postoperative symptoms was the visual analogue 
pain scale alone (pain was the main symptoms men-
tioned). No postoperative functional assessment on 
the Frankel scale was available to us in the patients’ 
medical files; instead, only the pain assessment was 
available. Because of the retrospective nature of this 
study, it was thus not possible to make a more detailed 
analysis on the clinical improvement.
Out of the 157 cases studied, 86.6% progressed 
to death. The maximum length of survival was 13.6 
years; the minimum was three days and the mean was 
13.2 months. Currently, 5.1% of the patients are still 
alive, for a maximum time of six years, minimum of 
18 months and mean of 3.6 years. The other 13 of the 
157 patients were lost from follow-up after a maxi-
mum of 6.08 years, minimum of 15 days and mean 
of 7.4 months (Box 12 and 13).
Box 5  - Primary site for metastases.
Organ from which metastasis 
originated
Absolute number %
 Prostate 33 21.0
 Breast 40 25.5
 Ocular orbit 2 1.3
 Multiple myeloma 14 8.9
 Palate 1 0.6
 Uterus 9 5.7
 Rectum 3 1.9
 Skin - melanoma 4 2.5
 Kidneys 6 3.8
 Stomach 3 1.9
 Placenta 1 0.6
 Lymphoma 4 2.5
 Primary site unknown 20 12.7
 Bladder 2 1.3
 Lungs 3 1.9
 Ewing’s sarcoma 2 1.3
 Retroperitoneal sarcoma 3 1.9
 Duodenal papilla 1 0.6
 Soft-tissue sarcoma 1 0.6
 Testicles 1 0.6
 Ovaries 1 0.6
 Colon 2 1.3
 Parathyroid 1 0.6
Total 157 100.0
Box 6 – Segment of the spine involved; more than one segment 
could be involved in the same patient.
Segment of the spine 
involved
Absolute number %
1- Cervical 25 15.9
2- Thoracic 104 66.2
3- Lumbar 103 65.6
4- Sacral 20 12.7
Box 7 – Number of segments of the spine affected per patient.









Box 8 – Preoperative symptoms.
Symptoms Absolute number %
1 Pain 140 89.2
2 Paresthesia 56 35.7
3 Paresis 37 23.6
4 Paraplegia 62 39.5
5 Intestinal constipation 3 1.9
6 Urine retention 2 1.3
Total 157 100 
Box 9 – Number of symptoms per patient.
Number of symptoms 
per patient
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Box 10 - Preoperative Frankel scale.








The scores among the cases operated according to 
the Tokuhashi scale presented the following frequen-
cies: up to 8 points, 111 cases; from 9 to 11 points, 43 
cases; and from 12 to 15 points, three cases (Box 14). 
The mean length of survival in months for all the 
157 patients is specified for each of the Tokuhashi 
groups in Box 15.
Box 11 – Postoperative improvement of pain.




Not specified 6 3.8
Total 157 100.0
Box 12 – Clinical evolution of the cases.
Clinical evolution Number %
Death 136 86.6





Box 13 – Length of survival in months.
Mean Maximum Minimum
Patients who progressed to death 13.2 163.0 0.1
Patients currently still alive 44.0 73.0 18.0
Patients lost from follow-up
(times refer to period until lost)
7.4 17.0 0.5







Box 15 – Length of survival in months according to Tokuhashi 
scores, obtained by testing the means to investigate differences 
between the means for each score group, at the significance 
level of 5%. P = 0.599.




Figure 3 – Comparison between the mean survival in months 
found in the study and the mean survival expected according to 
the modified Tokuhashi score.
DISCUSSION
Primary tumors in the spine are rare and represent 
less than 10% of bone tumors. The great majority of 
vertebral tumor lesions consist of secondary lesions, 
especially in adult patients(2). Around 50% to 70% of 
the patients who die because of malignant neoplasia 
present bone metastases in the spine(2,10). 
Over recent years, there have been major advances 
in the staging and treatment of tumor lesions. This has 
made longer survival possible for individuals with 
tumors in the spine, and especially for those who pre-
sent metastatic lesions, who have noticeably increased 
in numbers over the last few years(4,11). 
The literature shows that applying the Tokuhashi 
score is valid for determining the prognosis for the 
lives of patients affected by spinal metastases. This 
subsequently is of assistance in determining whether 
surgical or conservative treatment is indicated. Howe-
ver, other factors that are not evaluated or included 
in this and other similar scales, such as the degree of 
maturity of the neoplasia, stage of the disease at the 
time of diagnosis and degree of compromising of re-
nal function are also determinants of the prognosis(1) .
 Evaluations on surgical treatments for spinal tu-
mors present major limitations because of the hete-
rogeneity of the patient samples studied, with regard 
to the etiology of the tumor lesion. This creates di-
fficulty regarding the final assessment of the results, 
since it cannot be forgotten that tumors of differing
Rev Bras Ortop. 2011;46(4):424-30
Figure 3 compares the mean survival in months 
found in this study with the mean survival expected 
according to the Tokuhashi scale.
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etiologies present different biological behavior. It is 
very difficult to accumulate a significant number of 
patients with vertebral tumors of the same etiolo-
gy, and hence the studies that have been carried out 
present major limitations. With regard to the prima-
ry tumor, the data gathered from the patients in the 
present study were concordant with the literature, 
given that breast and prostate neoplasia were the 
most frequent origins for metastases.
Overall, other studies found that 70% of the cases 
had metastases located in the thoracic spine, 20% in 
the lumbar-sacral region, 10% in the cervical segment 
and 17-30% in more than one segment(2,3).  In our 
sample, the thoracic region was affected in 66.2%, the 
lumbar-sacral region in 78.3% and the cervical region 
in 15.9%, and in 49.7% of the cases, more than one 
segment of the spine was compromised. Contrary to 
the literature, we observed that the metastases were 
predominantly in the lumbar-sacral region, with a gre-
ater number of multiple metastases.
With regard to the treatment, given that the main 
determining factor for the type of treatment for ver-
tebral metastases is the prognosis, scores such as 
Tokuhashi help to determine the prognosis for the 
disease and to choose the therapy. However, they are 
not the only tool for indicating the type of treatment. 
Other, separate variables need to be taken into consi-
deration, such as: intractable pain; expansive lesions 
that do not respond to oncological treatments like 
radiotherapy, chemotherapy or hormone therapy; and 
spinal instability and spinal cord compression mani-
fested clinically(1). 
Of these symptoms, pain is the main manifestation 
in patients with metastatic bone lesions. Paraplegia 
may be another early sign caused by vertebral me-
tastasis. Patients with significant neurological defi-
cits but without paraplegia may present considerable 
improvement of their deficiencies through surgical 
treatment that aims to achieve decompression and 
stabilization. However, there is insufficient evidence 
to recommend routine surgical intervention for para-
plegic patients(2,12,13). In our study, the main symptom 
reported was also pain, which was present in 89.2% 
of the cases. Paraplegia was present in 39.5%, and 
paresthesia in 35.7%; 68.1% of the patients presen-
ted two or more symptoms in association. Regarding 
the improvement in symptoms after the operation 
among our sample, we observed that there was par-
tial or full alleviation of the pain in the majority of 
the cases (52.2%).
Surgical intervention is beneficial in the presence 
of metastatic disease in the spine, particularly with 
regard to alleviation of the pain symptoms caused by 
the metastasis, and to improvement of quality of life. 
However, there is insufficient evidence to ascertain 
whether survival is longer after surgery. Thus, surgery 
in such situations is palliative but improves patients’ 
quality of life, provided that the criteria for its indi-
cation are respected(4).
Regarding the indications for treatment in the 
present study, they were not based primarily on the 
prognosis for patients’ lives, given that in the cases 
presented here, the scores were applied retrospecti-
vely. The parameters for indicating treatment were: 
neurological deficit, instability due to fractures, or 
intractable pain that did not respond to conservative 
analgesia or radiotherapy measures. This approach 
was shown to be valid after retrospective analysis, 
given that the patients with poor prognoses achieved 
better quality of life. The distribution of the Tokuhashi 
scores for the cases operated at Hospital Erasto Ga-
ertner, in Curitiba, was as follows: 111 cases with 
up to eight points; 43 cases with 9 to 11 points and 
three cases with 12 to 15 points, such that scores of 
0-8 points had the worst prognosis and 12-15 had 
the best prognosis. The finding that most of our ca-
ses had scores between 1 and 8 represents the reality 
of an oncological reference hospital, to which cases 
of greater complexity are referred for evaluation by 
specialists in this field. However, even though the 
greatest number of cases belonged to the group with 
the worst prognosis according to the Tokuhashi sca-
le, we observed that the mean survival in this group 
(15.4 months) was greater than the expected mean 
survival for the same category (less than six months). 
In the other groups, the expected survival according to 
the Tokuhashi score was longer: 6-12 months for the 
group with 9-11 points and more than 12 months for 
the group with 12-15 points, and we observed that for 
our sample, the mean survival for these groups was wi-
thin the expectations: 11.4 and 12 months respectively.
We believe that although surgical treatment for 
spinal tumors is of large magnitude and not free 
from complications, it should not be postponed in the
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presence of the indications mentioned earlier, since 
accomplishing it may satisfactorily change the clinical 
evolution of this group of patients. However, surgical 
indications based on determining the patient’s prog-
nosis and expected length of survival using scores 
like Tokuhashi were not shown to be applicable in 
this study, considering that patients who, according 
to the modified Tokuhashi score, would not be indi-
cated for surgery because of the poor prognosis (score 
from 0 to 8) underwent operations within our service 
and achieved longer survival than would have been 
expected using the score. Thus, our study showed that 
there was also a benefit from surgically treating the 
patients whose prognoses were worse.
In this manner, in metastatic disease, each patient 
should be considered individually, and the decision re-
garding the best treatment method should be made af-
ter complete staging. Although this treatment is pallia-
tive, it is important to avoid an attitude of “disbelief 
and disregard”. The consequences of such an attitude 
could be disastrous and irreversible, and might lead 
patients and their families into inhuman situations. 
Despite the existence of many scales for assisting in 
making therapeutic indications and their validity for 
determining prognoses, good sense should be used in 
making decisions regarding the treatment objectives, 
methods and approaches, and this always requires 
a multidisciplinary team. Maintaining an active and 
proactive attitude regarding treatments for these me-
tastases may help to improve the patients’ quality of 
life, sometimes for a period of years. 
CONCLUSION
Although this study was a retrospective analysis 
and the therapeutic indications were not applied ba-
sed on the modified Tokuhashi scores, we formed an 
impression that the survival was longer in the group 
with worst prognosis than would be expected from 
the scores. Thus, differing from the non-surgical ap-
proach recommended for patients with lower scores, 
this group in our study was sent for surgery with bet-
ter results than those found for non-operated patients 
reported by Tokuhashi .
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